8-K

Company

Alaunos Therapeutics, Inc.

Filed

August 20, 2025

Period of Report

August 19, 2025

Accession Number

0000950170-25-110484

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →